Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

544.52
+2.830.52%
Post-market: 545.811.29+0.24%19:58 EDT
Volume:1.20M
Turnover:651.17M
Market Cap:138.15B
PE:31.69
High:546.84
Open:535.38
Low:532.23
Close:541.69
52wk High:555.69
52wk Low:374.17
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.46
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.82
PE(LYR):35.54

Loading ...

Intel, Micron, Spacex, GE Vernova, Caterpillar, and More Stocks That Explain Today's Market

Dow Jones
·
Jul 08

Top Midday Gainers

MT Newswires Live
·
Jul 08

Vertex Pharmaceuticals' Acquisition of Crinetics Adds Rare-Disease Drugs, UBS Says

MT Newswires Live
·
Jul 08

Sector Update: Healthcare

MT Newswires Live
·
Jul 08

Crinetics downgraded to Market Perform from Outperform at Citizens

TIPRANKS
·
Jul 08

Top Midday Stories: Amazon Seeking at Least $25 Billion From US Bond Sale; Fiserv Explores Sale of STAR Debit Network

MT Newswires Live
·
Jul 07

Wedbush sees BioCryst, Ascendis as potential next targets after Crinetics deal

TIPRANKS
·
Jul 07

Cantor Sees 'clear Strategic Rationale' Behind Vertex's Buy of Crinetics

Dow Jones
·
Jul 07

Vertex Sees Over $5 Billion Peak Sales Potential From Crinetics Assets

Benzinga
·
Jul 07

This Biotech Stock is Soaring 99% After Vertex Agrees to Takeover Deal

Dow Jones
·
Jul 07

Citi Remains a Buy on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jul 07

Vertex Pharmaceuticals is Maintained at Underperform by Baird

Dow Jones
·
Jul 07

Baird Adjusts Price Target on Vertex Pharmaceuticals to $350 From $330

MT Newswires Live
·
Jul 07

Major Deals Involving US Drugmakers and Biotechs over the Past Decade

Reuters
·
Jul 07

Deals of the Day-mergers and Acquisitions

Reuters
·
Jul 07

Why Is Crinetics Stock (CRNX) Surging Nearly 100% in Pre-Market Today, 7/7/26? Analysts React

TIPRANKS
·
Jul 07

Vertex’s $10 Billion Crinetics Acquisition Adds Endocrinology Growth Pillars, Supporting Long-Term Buy Thesis

TIPRANKS
·
Jul 07

Vertex to Buy Crinetics for $10 Billion in Rare-Diseases Push

Reuters
·
Jul 07

Vertex Minerals Launches $0.10 Share Purchase Plan for Existing Investors

TIPRANKS
·
Jul 07

PRESS Digest -wall Street Journal - July 7

Reuters
·
Jul 07